Viewing Study NCT05418868


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-02-12 @ 9:53 PM
Study NCT ID: NCT05418868
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2022-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Sponsor: ViiV Healthcare
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cabotegravir (CAB) View
None Rilpivirine (RPV) View
None Long-Acting Injection View
None Pharmacokinetics View
None Safety View
None Tolerability View